We are live on ! Find out more
SYRA

Syra Health Corp. Class A Common Stock

Delisted

SYRA was delisted on the 17th of April, 2025.

13 hedge funds and large institutions have $299K invested in Syra Health Corp. Class A Common Stock in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

215% more capital invested

Capital invested by funds: $94.8K → $299K (+$204K)

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

44% more funds holding

Funds holding: 913 (+4)

Holders
13
Holders Change
+4
Holders Change %
+44.44%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
5
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CCC
1
Cable Car Capital
California
$110K +$274K +258,315 New
WAM
2
Warberg Asset Management
Illinois
$88.3K +$221K +208,246 New
Citadel Advisors
3
Citadel Advisors
Florida
$25.5K +$63.9K +60,222 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$22K +$18.8K +17,728 +52%
VF
5
Virtu Financial
New York
$13K +$31.4K +29,595 New
TSS
6
Two Sigma Securities
New York
$11K +$27.5K +25,965 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$9.27K +$9.41K +8,875 +68%
XT
8
XTX Topco
Cayman Islands
$6.42K +$1.98K +1,865 +14%
HF
9
HRT Financial
New York
$6K +$16.7K +15,765 New
IWM
10
IHT Wealth Management
Illinois
$4.66K +$11.7K +11,000 New
TRCT
11
Tower Research Capital (TRC)
New York
$2.69K +$466 +439 +7%
NA
12
NewEdge Advisors
Louisiana
$424
Bank of America
13
Bank of America
North Carolina
$98 +$227 +214 +1,338%
UBS Group
14
UBS Group
Switzerland
-$2.28K -1,665 Closed
Fidelity Investments
15
Fidelity Investments
Massachusetts
-$166 -121 Closed
JP Morgan Chase
16
JP Morgan Chase
New York
-$14 -10 Closed

SYRA Hedge Fund Activity: Q3 2024 in Review

13 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Syra Health Corp. Class A Common Stock (SYRA) for Q3 2024, worth a combined $299K — up 215% from $94.8K a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new SYRA positions and 3 closed out — a net gain of 4 holders — while 5 added to existing stakes and 0 trimmed.

The largest buyer was Cable Car Capital, opening a new position worth an estimated $274K. The largest seller was UBS Group, exiting entirely with an estimated $2.28K sold.

  • 13 institutional investors held Syra Health Corp. Class A Common Stock (SYRA) as of Q3 2024, up from 9 in Q2 2024.
  • Funds reported $299K of Syra Health Corp. Class A Common Stock stock for Q3 2024, up 215% quarter-over-quarter.
  • 7 funds opened new Syra Health Corp. Class A Common Stock positions in Q3 2024 and 3 closed out, a net change of +4 holders.
  • The largest Syra Health Corp. Class A Common Stock buyer in Q3 2024 was Cable Car Capital, an estimated $274K added.
  • The largest Syra Health Corp. Class A Common Stock seller in Q3 2024 was UBS Group, an estimated $2.28K sold.

Based on aggregated 13F filings for Q3 2024.